FDA staff flags eye safety risks for GSK's blood cancer drug | Reuters
FDA staff flags eye safety risks for GSK's blood cancer drug. By ... Discover the key points from this story with Reuters AI . Try Reuters AI .
Read the original at Reuters ↗
- Topics
- HealthcareAI Safety & Existential Risk
- Mentions
- FDA
- Tracked via
- “AI Risks”